NO840074L - Vaeskeformige, adhererende desinfiseringsmiddel - Google Patents
Vaeskeformige, adhererende desinfiseringsmiddelInfo
- Publication number
- NO840074L NO840074L NO840074A NO840074A NO840074L NO 840074 L NO840074 L NO 840074L NO 840074 A NO840074 A NO 840074A NO 840074 A NO840074 A NO 840074A NO 840074 L NO840074 L NO 840074L
- Authority
- NO
- Norway
- Prior art keywords
- casein
- detergent
- aliphatic
- weight
- medium
- Prior art date
Links
- 239000000645 desinfectant Substances 0.000 title claims description 22
- 239000007788 liquid Substances 0.000 title claims description 8
- 239000000853 adhesive Substances 0.000 title description 3
- 230000001070 adhesive effect Effects 0.000 title description 3
- 239000005018 casein Substances 0.000 claims description 54
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 54
- 235000021240 caseins Nutrition 0.000 claims description 54
- 239000003599 detergent Substances 0.000 claims description 50
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 239000002609 medium Substances 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 23
- 239000004310 lactic acid Substances 0.000 claims description 23
- 235000014655 lactic acid Nutrition 0.000 claims description 23
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 125000001931 aliphatic group Chemical group 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 10
- 235000013336 milk Nutrition 0.000 claims description 10
- 239000008267 milk Substances 0.000 claims description 10
- 210000004080 milk Anatomy 0.000 claims description 10
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 9
- -1 ammonium aliphatic sulfates Chemical class 0.000 claims description 9
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 7
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 235000013861 fat-free Nutrition 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 5
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 5
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 5
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000010419 fine particle Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 claims description 2
- 238000011200 topical administration Methods 0.000 claims description 2
- 230000001464 adherent effect Effects 0.000 claims 4
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 239000000047 product Substances 0.000 description 24
- 210000002445 nipple Anatomy 0.000 description 19
- 208000004396 mastitis Diseases 0.000 description 13
- 230000003115 biocidal effect Effects 0.000 description 10
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 7
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 235000010199 sorbic acid Nutrition 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004902 Softening Agent Substances 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 2
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 2
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000013020 final formulation Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 235000020122 reconstituted milk Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000031462 Bovine Mastitis Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186866 Lactobacillus thermophilus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000194042 Streptococcus dysgalactiae Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 108010038836 acidolin Proteins 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010952 in-situ formation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940068140 lactobacillus bifidus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940030998 streptococcus agalactiae Drugs 0.000 description 1
- 229940115920 streptococcus dysgalactiae Drugs 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/457,212 US4525351A (en) | 1983-01-11 | 1983-01-11 | Liquid adherent disinfectant compositions for topical application and method of preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO840074L true NO840074L (no) | 1984-07-12 |
Family
ID=23815856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO840074A NO840074L (no) | 1983-01-11 | 1984-01-10 | Vaeskeformige, adhererende desinfiseringsmiddel |
Country Status (5)
Country | Link |
---|---|
US (1) | US4525351A (fi) |
EP (1) | EP0113396A3 (fi) |
DK (1) | DK554283A (fi) |
FI (1) | FI840084A (fi) |
NO (1) | NO840074L (fi) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
US4945110A (en) * | 1987-06-15 | 1990-07-31 | Quali Tech, Inc. | Membrame-forming veterinary antibacterial teat dip |
US4942032A (en) * | 1988-09-23 | 1990-07-17 | Microlife Technics, Inc. | Process for producing a novel antifungal product |
US5269959A (en) * | 1992-09-16 | 1993-12-14 | Gary Schreibman | Liquid deep cleaning detergent composition |
DE4428624C2 (de) * | 1994-08-12 | 1996-09-19 | Kanne Brottrunk Gmbh & Betrieb | Reinigungs- und Desinfektionsmittel |
AU2001287560A1 (en) * | 2000-07-14 | 2002-01-30 | Societe Des Produits Nestle S.A. | Agent for inhibiting adhesion of the pathogenic flora of the skin |
US20030045428A1 (en) * | 2001-07-05 | 2003-03-06 | Microbes, Inc. | Bacillus laterosporus strain CM-3 for promoting grain crop yields |
FR2855181A1 (fr) * | 2003-05-23 | 2004-11-26 | Rhodia Chimie Sa | Composition detergente a activite anti-microbienne |
US7795000B2 (en) * | 2004-09-24 | 2010-09-14 | Ecolab Inc. | Foaming composition of competitive exclusion microbes and methods of using same |
DK2988763T3 (da) | 2013-04-23 | 2023-10-16 | Terragen Holdings Ltd | Bakteriestamme med antimikrobiel aktivitet anvendt på planter |
CN106676020A (zh) * | 2015-11-06 | 2017-05-17 | 中创云牧科技咨询(北京)股份有限公司 | 一种乳酸菌在调制青贮饲料及预防奶牛乳房炎的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL201469A (fi) * | 1954-10-26 | |||
US3262884A (en) * | 1963-01-16 | 1966-07-26 | Chemical Supplies Inc | Skin cleaning composition |
US3689640A (en) * | 1967-09-28 | 1972-09-05 | Univ Of Nebraska The | Antibiotic acidophilin and process of preparing the same |
GB1496671A (en) * | 1975-03-27 | 1977-12-30 | Grindstedvaerket As | Anti-cancer-active sour milk fraction |
US4199564A (en) * | 1978-09-22 | 1980-04-22 | Masti-Kure Products Company, Inc. | Film-forming alcoholic microbicidal teat dip and method of use thereof |
JPS56113708A (en) * | 1980-02-12 | 1981-09-07 | Dso Pharmachim | Enzymeedecomposed freezeedried substance and its manufacture |
-
1983
- 1983-01-11 US US06/457,212 patent/US4525351A/en not_active Expired - Lifetime
- 1983-10-13 EP EP83110231A patent/EP0113396A3/en not_active Ceased
- 1983-12-01 DK DK554283A patent/DK554283A/da not_active Application Discontinuation
-
1984
- 1984-01-10 NO NO840074A patent/NO840074L/no unknown
- 1984-01-10 FI FI840084A patent/FI840084A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK554283D0 (da) | 1983-12-01 |
FI840084A (fi) | 1984-07-12 |
US4525351A (en) | 1985-06-25 |
DK554283A (da) | 1984-07-12 |
FI840084A0 (fi) | 1984-01-10 |
EP0113396A2 (en) | 1984-07-18 |
EP0113396A3 (en) | 1985-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4945110A (en) | Membrame-forming veterinary antibacterial teat dip | |
McSweeney et al. | A procedure for the manufacture of Cheddar cheese under controlled bacteriological conditions and the effect of adjunct lactobacilli on cheese quality | |
Klostermann et al. | Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis | |
EP0934075B1 (en) | Micrococcin atibiotic for the prevention and treatment of mastitis | |
US4169160A (en) | Dried soft curd cheese | |
Visser | Contribution of enzymes from rennet, starter bacteria and milk to proteolysis and flavour development in Gouda cheese. 1. Description of cheese and aseptic cheesemaking techniques | |
NO840074L (no) | Vaeskeformige, adhererende desinfiseringsmiddel | |
NO314432B1 (no) | Anvendelse av et micell¶rt kasein | |
EP0323109B1 (en) | Treatment of mastitis and applicator therefor | |
US5130148A (en) | Method of cheese manufacture | |
RU2291623C1 (ru) | Способ производства сырного продукта | |
US5710124A (en) | Method for combatting bovine mastitis | |
JPH1099018A (ja) | 乳酸酸度上昇が抑制された乳酸菌発酵乳材料 | |
RU2560277C1 (ru) | Средство для профилактики мастита у коров в период лактации | |
Oura et al. | Efficacy of two acidified chlorite postmilking teat disinfectants with sodium dodecylbenzene sulfonic acid on prevention of contagious mastitis using an experimental challenge protocol | |
EP1481666A1 (en) | A composition for re-establishment of the vaginal ecosystem | |
Boddie et al. | Germicidal activity of a chlorous acid-chlorine dioxide teat dip and a sodium chlorite teat dip during experimental challenge with Staphylococcus aureus and Streptococcus agalactiae | |
Tham | Survival of Listeria monocytogenes in cheese made of unpasteurized goat milk | |
IE63395B1 (en) | Method for the preparation of cheese | |
CN1735392A (zh) | 涂覆含乳酸菌组成物的保险套 | |
CN117821309B (zh) | 一株鼠李糖乳杆菌Lr-HS56及其用于女性私密制品的应用 | |
RU2086140C1 (ru) | Способ получения концентрата молочнокислых бактерий | |
SU615862A3 (ru) | Способ получени фермента, створаживающего молоко | |
EP1101407B1 (en) | Method for preparing a hard or half-hard cheese utilizing extracellular polysaccharide-producing bacteria, and a cheese thus obtained | |
SU1731141A1 (ru) | Штамм бактерий SтRертососсUS тнеRморнILUS, используемый в составе бактериальных заквасок дл производства творога |